Company intelligence / Profile preview

RadioSight

Hoboken, New Jersey, United States

Ownership: Private
Development stage: Other

Overview

RadioSight was a private U.S. healthcare technology company developing an ultra-wideband millimeter-wave imaging device for skin cancer diagnosis and surgical guidance. Its core approach was a handheld, point-of-care imaging platform designed to visualize suspicious tissue and help define lesion margins before biopsy or surgery. The company appears to have operated at an early development stage rather than as a clinical-stage therapeutics developer, and public information points to grant-backed product development rather than commercial sales. RadioSight was founded in 2020 and based in Hoboken, New Jersey. Available company databases now classify the business as closed.

Therapeutic areas: Oncology
Modalities: Device
Industry: Medical Imaging

Beyond the preview

Go deeper on RadioSight.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on RadioSight.

Explore the full profile